Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial by Price Matthew J, Berger Peter B, Teirstein Paul S, Tanguay Jean-Fran├žois, Angiolillo Dominick J, Spriggs Douglas, Puri Sanjeev, Robbins Mark, Garratt Kirk N, Bertrand Olivier F, Stillabower Michael E, Stillablower Michael E, Aragon Joseph R, Kandzari David E, Stinis Curtiss T, Lee Michael S, Manoukian Steven V, Cannon Christopher P, Schork Nicholas J, Topol Eric J, GRAVITAS Investigators in JAMA : the journal of the American Medical Association (2011). PubMed

Abstract

High platelet reactivity while receiving clopidogrel has been linked to cardiovascular events after percutaneous coronary intervention (PCI), but a treatment strategy for this issue is not well defined.

[ hide abstract ]

Discussed In Paper